Might be age related with Sinovac as as a more mature member at 74 I had fatigue and a few headaches on day 2 after my second Sinovac... feel fine now. Think another third shot of Sinovac (or better still a higher quality vaccine) within 3 months might finally really kick those antibodies into business!
Got my Vaccine, Johnson&Johnson, today in Sibulan for seniors. More then 100 people before 8 am. Was lucky to get nr. 34. Done at 9.30 am. So far, I'm good.
I got my Johnson & Johnson at the sports complex last Monday and had a raging headache all day Tuesday feeling fine now. That's the end of the Johnson & Johnson back to Sinovac
I broached the subject with my wife, as it looks like Covid will be around and booster shots will be needed. The shot availability here is limited and improvement isn't on the horizon. Being subject to rolling lockdowns is wearing, and there are other advantages. I probably would still enjoy it here, but there's advantages to the states. But it probably won't be for another six months.
Interesting News about SINOVAC.....https://www.focus.de/gesundheit/new...wirkt-wohl-nur-wenige-monate_id_13537996.html....translate the page to english if needed
Money slowed the process initially. The Phils got some loans. There is vaccine hesitancy here, and the anti-vax BS gets translated and passed around. Used to be Sinovac and Aztrazeneca, with a limited few Pfizer, were the only jabs around and no one trusted Sinovac. Sinopharm was the problem in the Seychelles and Indonesia. then Thailand got hit, Vietnam, the whole schmear. Jansen is a good as long as you know the odds: Since use of COVID-19 vaccines began in the United States, scientists and doctors have constantly and carefully reviewed all reports of vaccine side effects and adverse events. As of April 23, 2021, more than 8 million doses of the J&J/Janssen COVID-19 Vaccine had been given in the United States. As of April 23, 2021, experts reviewing safety reports for this vaccine found 15 reports of women who got the J&J/Janssen COVID-19 Vaccine and later developed thrombosis with thrombocytopenia syndrome (TTS). TTS is a serious condition that involves blood clots with low platelets. These reports suggest an increased risk of TTS one to two weeks after vaccination with the J&J/Janssen COVID-19 Vaccine. As of April 23, 2021, the reports reviewed all occurred in women between 18 and 59 years old, with a median of 37 years. These reports represent a reporting rate of 7 such events per 1 million vaccinations among women 18 through 49 years old and a rate of 0.9 per 1 million vaccinations among women 50 years and older. For all women, this is a rare adverse event. For women 50 years and older and men of all ages, the adverse event is even more rare. Reports show that symptoms of this adverse event started between 6 and 15 days after vaccination. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/JJUpdate.html
Is that German? Can't get page to translate. Is it by any chance that big report from South America? Then I know it.
